儿童序贯器官衰竭评估评分的适配与验证及Sepsis-3定义在危重患儿中的评估
本研究在6303例危重患儿中适配并验证了年龄调整的儿童序贯器官衰竭评估评分(pSOFA),并评估Sepsis-3定义。最大pSOFA评分对院内死亡具有优异区分度(AUC 0.94,95%CI 0.92-0.95)。按Sepsis-3定义,14.1%患儿为脓毒症(死亡率12.1%),4.0%为脓毒性休克(死亡率32.3%)。
要点
- pSOFA评分对危重患儿院内死亡具有优异区分度,AUC为0.94。
- 按Sepsis-3定义,脓毒症患儿死亡率12.1%,脓毒性休克患儿死亡率32.3%。
- 脓毒症患儿死亡风险显著高于疑似感染但无脓毒症患儿(OR 18,95%CI 11-28)。
核心结论
- pSOFA评分经年龄调整变量适配并验证,可用于危重患儿器官功能障碍评估。
- 使用pSOFA评分评估Sepsis-3定义在儿童中可行且结果有前景。
研究设计与样本
- 回顾性观察性队列研究,纳入2009年1月1日至2016年8月1日单中心20张床位的三级儿科重症监护病房收治的21岁及以下危重患儿。
- 共6303例患者、8711次就诊纳入分析,每次就诊独立处理。
- pSOFA评分通过年龄调整心血管和肾脏系统 cutoff 并扩展呼吸标准纳入无创肺损伤替代指标而建立。
主要发现
- 存活出院者8482例中4644例(54.7%)为男性,中位年龄69(IQR 17-156)个月。
- 死亡者229例中127例(55.4%)为男性,中位年龄43(IQR 8-144)个月。
- 院内死亡率为2.6%。
- 最大pSOFA评分对院内死亡的AUC为0.94(95%CI 0.92-0.95)。
- pSOFA评分性能与其他儿科器官功能障碍评分相似或更优。
关键数值与推荐
- 按Sepsis-3定义,1231例患者(14.1%)被分类为脓毒症,死亡率为12.1%。
- 347例(4.0%)为脓毒性休克,死亡率为32.3%。
- 脓毒症患者死亡风险高于确诊或疑似感染但无脓毒症患者(OR 18,95%CI 11-28)。
- 229例住院死亡患者中149例(65.0%)病程中出现脓毒症或脓毒性休克。
临床怎么用
- 在危重患儿中可使用年龄调整的pSOFA评分评估器官功能障碍和死亡风险。
- Sepsis-3定义可用于儿童脓毒症和脓毒性休克的分类,有助于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) uses the Sequential Organ Failure Assessment (SOFA) score to grade organ dysfunction in adult patients with suspected infection. However, the SOFA score is not adjusted for age and therefore not suitable for children. OBJECTIVES: To adapt and validate a pediatric version of the SOFA score (pSOFA) in critically ill children and to evaluate the Sepsis-3 definitions in patients with confirmed or suspected infection. DESIGN, SETTING, AND PARTICIPANTS: This retrospective observational cohort study included all critically ill children 21 years or younger admitted to a 20-bed, multidisciplinary, tertiary pediatric intensive care unit between January 1, 2009 and August 1, 2016. Data on these children were obtained from an electronic health record database. The pSOFA score was developed by adapting the original SOFA score with age-adjusted cutoffs for the cardiovascular and renal systems and by expanding the respiratory criteria to include noninvasive surrogates of lung injury. Daily pSOFA scores were calculated from admission until day 28 of hospitalization, discharge, or death (whichever came first). Three additional pediatric organ dysfunction scores were calculated for comparison. EXPOSURES: Organ dysfunction measured by the pSOFA score, and sepsis and septic shock according to the Sepsis-3 definitions. MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality. The daily pSOFA scores and additional pediatric organ dysfunction scores were compared. Performance was evaluated using the area under the curve. The pSOFA score was then used to assess the Sepsis-3 definitions in the subgroup of children with confirmed or suspected infection. RESULTS: In all, 6303 patients with 8711 encounters met inclusion criteria. Each encounter was treated independently. Of the 8482 survivors of hospital encounters, 4644 (54.7%) were male and the median (interquartile range [IQR]) age was 69 (17-156) months. Among the 229 nonsurvivors, 127 (55.4%) were male with a median (IQR) age of 43 (8-144) months. In-hospital mortality was 2.6%. The maximum pSOFA score had excellent discrimination for in-hospital mortality, with an area under the curve of 0.94 (95% CI, 0.92-0.95). The pSOFA score had a similar or better performance than other pediatric organ dysfunction scores. According to the Sepsis-3 definitions, 1231 patients (14.1%) were classified as having sepsis and had a mortality rate of 12.1%, and 347 (4.0%) had septic shock and a mortality rate of 32.3%. Patients with sepsis were more likely to die than patients with confirmed or suspected infection but no sepsis (odds ratio, 18; 95% CI, 11-28). Of the 229 patients who died during their hospitalization, 149 (65.0%) had sepsis or septic shock during their course. CONCLUSIONS AND RELEVANCE: The pSOFA score was adapted and validated with age-adjusted variables in critically ill children. Using the pSOFA score, the Sepsis-3 definitions were assessed in children with confirmed or suspected infection. This study is the first assessment, to date, of the Sepsis-3 definitions in critically ill children. Use of these definitions in children is feasible and shows promising results.
引用
- Matics TJ, Sanchez-Pinto LN. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017. PMID: 28783810. doi:10.1001/jamapediatrics.2017.2352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。